The pathogenesis of fatigue in multiple sclerosis (MS) is poorly understood.
Objective
To elucidate the role of central motor activation we hypothesized that patients with primary fatigue have impaired central motor function and increased fatigability as compared to secondary fatigued and non-fatigued patients.
Methods
Sixty patients with relapsing remitting MS and an Expanded Disability Status Scale score ≤ 3.5 were recruited and grouped as fatigued (Fatigue Severity Scale (FSS) ≥ 5.0) or non-fatigued (FSS ≤ 4.0). Nineteen patients were primary fatigued, 20 secondary fatigued and 21 non-fatigued. Maximal voluntary contraction, central activation and peripheral activation were determined by percutaneous twitch interpolation of the right quadriceps muscle.
Results
Maximal voluntary contraction was similar between groups but did relate to scores of fatigue. Peripheral activation was similar in all groups. Central activation was impaired in both groups of fatigued patients compared to non-fatigued patients being 0.96(0.05) in primary fatigued and 0.96(0.04) in secondary fatigued versus 0.99(0.1) in non-fatigued patients. The impairment of central motor activation was related to degree of fatigue in all patients. During fatiguing exercise there was a similar loss of strength, without any time differences between the three groups.
Conclusion
We conclude that impaired central motor activation is involved in MS-fatigue.
1 Lerdal A Celius EG Krupp L Dahl AA . A prospective study of patterns of fatigue in multiple sclerosis. Eur J Neurol2007; 14: 1338–1343.
2.
2 Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis.Washington (DC): Paralyzed Veterans of America; 1998. http://pva.convio.net/site/News2?page=NewsArticle&id=8101.
3.
3 Gandevia SC . Spinal and supraspinal factors in human muscle fatigue. Physiol Rev2001; 81: 1725–1789.
4.
4 Iriarte J de Castro P . Correlation between symptom fatigue and muscular fatigue in multiple sclerosis. Eur J Neurol1998; 5: 579–585.
5.
5 Lambert CP Archer RL Evans WJ . Muscle strength and fatigue during isokinetic exercise in individuals with multiple sclerosis. Med Sci Sports Exerc2001; 33: 1613–1619.
6.
6 Surakka J Romberg A Ruutiainen J Virtanen A Aunola S Maentaka K . Assessment of muscle strength and motor fatigue with a knee dynamometer in subjects with multiple sclerosis: a new fatigue index. Clin Rehabil2004; 18: 652–659.
7.
7 Kent-Braun JA Ng AV Castro M . Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. J Appl Physiol1997; 83: 1998–2004.
8.
8 Kent-Braun JA Sharma KR Miller RG Weiner MW . Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis. Muscle Nerve1994; 17: 835–841.
9.
9 Sharma KR Kent-Braun J Mynhier MA Weiner MW Miller RG . Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis. Muscle Nerve1995; 18: 1403–1411.
10.
10 Kent-Braun JA Sharma KR Weiner MW Miller RG . Effects of exercise on muscle activation and metabolism in multiple sclerosis. Muscle Nerve1994; 17: 1162–1169.
11.
11 Thickbroom GW Sacco P Kermode AG . Central motor drive and perception of effort during fatigue in multiple sclerosis. J Neurol2006; 253: 1048–1053.
12.
12 de Haan A de Ruiter CJ van Der Woude LH Jongen PJ . Contractile properties and fatigue of quadriceps muscles in multiple sclerosis. Muscle Nerve2000; 23: 1534–1541.
13.
13 Latash M Kalugina E Nicholas J Orpett C Stefoski D Davis F . Myogenic and central neurogenic factors in fatigue in multiple sclerosis. Mult Scler1996; 1: 236–241.
14.
14 Rice CL Vollmer TL Bigland-Ritchie B . Neuromuscular responses of patients with multiple sclerosis. Muscle Nerve1992; 15: 1123–1132.
15.
15 Liepert J Mingers D Heesen C Baumer T Weiller C . Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler2005; 11: 316–321.
16.
16 Roelcke U Kappos L Lechner-Scott J . Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology1997; 48: 1566–1571.
17.
17 Filippi M Rocca MA Colombo B . Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage2002; 15: 559–567.
18.
18 Mainero C Inghilleri M Pantano P . Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine. Neurology2004; 62: 2044–2050.
19.
19 Ng AV Miller RG Gelinas D Kent-Braun JA . Functional relationships of central and peripheral muscle alterations in multiple sclerosis. Muscle Nerve2004; 29: 843–852.
20.
20 Sheean GL Murray NM Rothwell JC Miller DH Thompson AJ . An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain1997; 120(Pt 2): 299–315.
21.
21 Schwid SR Covington M Segal BM Goodman AD . Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev2002; 39: 211–224.
22.
22 van Kessel K Moss-Morris R . Understanding multiple sclerosis fatigue: a synthesis of biological and psychological factors. J Psychosom Res2006; 61: 583–585.
23.
23 Krupp LB LaRocca NG Muir-Nash J Steinberg AD . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46: 1121–1123.
24.
24 Lloyd AR Gandevia SC Hales JP . Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. Brain1991; 114(Pt 1A): 85–98.
25.
25 Merton PA . Voluntary strength and fatigue. J Physiol1954; 123: 553–564.
26.
26 Poser CM Paty DW Scheinberg L . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983; 13: 227–231.
27.
27 Polman CH Reingold SC Edan G . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
28.
28 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
29.
29 Janardhan V Bakshi R . Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci2002; 205: 51–58.
30.
30 Bakshi R Shaikh ZA Miletich RS . Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler2000; 6: 181–185.
31.
31 Tellez N Rio J Tintore M Nos C Galan I Montalban X . Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler2005; 11: 198–202.
32.
32 Buysse DJ Reynolds CF Monk TH Berman SR Kupfer DJ . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res1989; 28: 193–213.
33.
33 Bech P Olsen LR Kjoller M Rasmussen NK . Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res2003; 12: 85–91.
34.
34 Bonsignore M Barkow K Jessen F Heun R . Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci2001; 251(Suppl. 2): II27–II31.
35.
35 Bech P Rasmussen NA Olsen LR Noerholm V Abildgaard W . The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord2001; 66: 159–164.
36.
36 Marrie RA Cutter G Tyry T Hadjimichael O Vollmer T . Validation of the NARCOMS Registry: pain assessment. Mult Scler2005; 11: 338–342.
37.
37 Bohannon RW Smith MB . Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther1987; 67: 206–207.
38.
38 Smets EM Garssen B Bonke B De Haes JC . The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res1995; 39: 315–325.
39.
39 Watt T Groenvold M Bjorner JB Noerholm V Rasmussen NA Bech P . Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Community Health2000; 54: 827–833.
40.
40 ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med2002; 166: 111–117.
41.
41 Shield A Zhou S . Assessing voluntary muscle activation with the twitch interpolation technique. Sports Med2004; 34: 253–267.
42.
42 Morton JP Atkinson G MacLaren DP . Reliability of maximal muscle force and voluntary activation as markers of exercise-induced muscle damage. Eur J Appl Physiol2005; 94: 541–548.
43.
43 Crayton HJ Rossman HS . Managing the symptoms of multiple sclerosis: a multimodal approach. Clin Ther2006; 28: 445–460.
44.
44 McDonald WI Sears TA . The effects of experimental demyelination on conduction in the central nervous system. Brain1970; 93: 583–598.
45.
45 Sandroni P Walker C Starr A . ‘Fatigue’ in patients with multiple sclerosis. Motor pathway conduction and event-related potentials. Arch Neurol1992; 49: 517–524.
46.
46 Gandevia SC Allen GM Butler JE Taylor JL . Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex. J Physiol1996; 490(Pt 2): 529–536.
47.
47 Woods JJ Furbush F Bigland-Ritchie B . Evidence for a fatigue-induced reflex inhibition of motoneuron firing rates. J Neurophysiol1987; 58: 125–137.
48.
48 Bigland-Ritchie B Woods JJ . Changes in muscle contractile properties and neural control during human muscular fatigue. Muscle Nerve1984; 7: 691–699.
49.
49 Leocani L Colombo B Magnani G . Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement–EEG evidence. Neuroimage2001; 13: 1186–1192.
50.
50 Tartaglia MC Narayanan S Francis SJ . The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol2004; 61: 201–207.
